This HTML5 document contains 187 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n13http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n7https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33889548
rdf:type
wikibase:Item
schema:description
επιστημονικό άρθρο vitskapeleg artikkel مقالهٔ علمی artigo científico (publicado na 2010) teaduslik artikkel 2010年論文 artikulong pang-agham บทความทางวิทยาศาสตร์ سائنسی مضمون наукова стаття, опублікована у квітні 2010 artykuł naukowy 2010年論文 videnskabelig artikel (udgivet 2010) scientific article 2010年の論文 2010年论文 2010年論文 article scientifique (publié 2010) научна статия 2010年论文 artículo científico publicado en 2010 artigo científico articolo scientifico mokslinis straipsnis מאמר מדעי 2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած artigo científico (publicado na 2010) artikull shkencor научни чланак 2010년 논문 мақолаи илмӣ სამეცნიერო სტატია articol științific vedecký článok мақолаи илмӣ tieteellinen artikkeli article científic 2010 nî lūn-bûn vědecký článek bài báo khoa học 2010年论文 tudományos cikk bilimsel makale 2010年論文 научни чланак wetenschappelijk artikel 2010年论文 naučni članak 2010年论文 مقالة علمية 2010年論文 ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitenskapelig artikkel article scientific 2010 թվականի ապրիլին հրատարակված գիտական հոդված 2010年论文 scienca artikolo wissenschaftlicher Artikel научная статья vetenskaplig artikel artículu científicu espublizáu en 2010
p:P577
wds:Q33889548-DCD6BE8A-D796-4610-B7CF-A5B415EC6723
wdt:P577
2010-04-16T00:00:00Z
p:P2888
wds:Q33889548-AD525BB9-C771-4365-9C00-C40545626D9A
wdt:P2888
n7:bcr2565
p:P2860
wds:Q33889548-E461A154-2DD4-4D59-A08F-86EEE8F15042 wds:Q33889548-E5D1AD53-AEDE-4AA4-954B-FA3A6455D262 wds:Q33889548-E6B9F35E-68D9-4516-A71C-6968448F41FB wds:Q33889548-E6C6186C-F674-41D2-91D3-C3145A58212D wds:Q33889548-C92E7B35-27E4-43A4-BA3D-6DE46CB7FE56 wds:Q33889548-D267271D-39BA-4799-B4D2-5FFB566195AC wds:Q33889548-AAD367E3-DEB8-44DF-A93F-E9DA59300923 wds:Q33889548-BC121442-8E1F-461B-9A77-1BFF59A10C71 wds:Q33889548-BCDDC951-C95E-4F11-A8C7-6107D5A22C60 wds:Q33889548-6B5256FF-C3BE-4C14-9618-53BE2578A9F2 wds:Q33889548-7BDBD63A-F059-451B-8C7E-5470DF35B250 wds:Q33889548-7E8E6D73-AD44-490B-82CD-AC8424C39CC5 wds:Q33889548-7FA0727F-FC0F-44BC-97C7-895E5FB49B43 wds:Q33889548-3C305A6C-9521-48A2-8007-A3437953A949 wds:Q33889548-4CE619AC-154D-4A43-932F-A6823BF7DD7C wds:Q33889548-53764447-681F-4465-8164-57F60D41773E wds:Q33889548-5D85C280-547F-48B0-B78A-F614CD357FBA wds:Q33889548-62F86EE3-4DFA-4D13-AD03-230F1037686D wds:Q33889548-285BD983-1D0B-4BDC-BFE2-7A41BA909214 wds:Q33889548-325AD295-41A9-44D1-8A8A-66CEAAE797F7 wds:Q33889548-32919D5D-4055-41EB-8EC2-61E13399A235 wds:Q33889548-34BE4D37-9C76-451F-8B08-2DCF109D47F5 wds:Q33889548-0505FF69-104D-4A10-BDF8-A6619D7B22BE wds:Q33889548-0FC70FEB-6E64-4F73-95CE-6007CF456D52 wds:Q33889548-0FD4733F-8F7B-4F87-B8DC-687E91E7FB69 wds:Q33889548-02769EF3-2C90-4510-9C1D-62B4097C2CE8 wds:Q33889548-02ADA8D0-E343-4961-8C9A-CD9D8406CB3A wds:Q33889548-0314D21A-AEC9-4D97-8268-3F81599E36D4
wdt:P2860
wd:Q43235108 wd:Q46016026 wd:Q34943802 wd:Q44265649 wd:Q77669938 wd:Q43197341 wd:Q44045676 wd:Q37151578 wd:Q36656547 wd:Q78306109 wd:Q37027847 wd:Q37342629 wd:Q46336448 wd:Q46121548 wd:Q59616816 wd:Q36170092 wd:Q37533796 wd:Q34190995 wd:Q37006572 wd:Q44635849 wd:Q34382805 wd:Q53579533 wd:Q79995276 wd:Q46801197 wd:Q37415072 wd:Q35121710 wd:Q35951294 wd:Q34563755
p:P2093
wds:Q33889548-F57B5693-7E60-4C6F-892A-0D9756832E85 wds:Q33889548-DF3C3484-4116-4558-99D7-3F62D09DD19C wds:Q33889548-DA7D5CB7-6637-4C56-B4E8-9B289F894506 wds:Q33889548-DB39A2C4-BD61-4D5D-B8C6-07F722C65630 wds:Q33889548-D1EF3038-4821-4610-96C0-349213CA89F3 wds:Q33889548-0ED421DC-5431-411A-A554-6E9AF7A899E2 wds:Q33889548-37B30DBB-2257-4C6D-BE12-C4D38613D443 wds:Q33889548-32A05476-3F2B-4F3A-A185-318116B46FBE wds:Q33889548-304B3414-EF23-4F3A-99BB-DCDEAEC32F73 wds:Q33889548-AFF922F2-1B0D-4CAC-B41F-734CE6327065 wds:Q33889548-A7BE4584-1145-4419-A20D-A832CAA7D8F9 wds:Q33889548-9180CD5D-0146-4E76-BC09-E530DB74B89D wds:Q33889548-773FA162-8BC1-42CB-B816-607C0318EC35
wdt:P2093
Kyriakos Kalogerakos Angeliki Sarantopoulou John Papadiamantis Vasilios Zobolas Dimitrios Koukouras Evagelos Tzoracoleftherakis Grigorios Xepapadakis Basileios Venizelos Helen Gogas Spyros Lazarou John Misitzis Athanassios Polychronis Zoh Antonopoulou
rdfs:label
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.
skos:prefLabel
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.
schema:name
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.
p:P50
wds:Q33889548-652B3C7E-17D2-4788-A54B-5325A8FE24B0 wds:Q33889548-BA4800F0-24AD-414B-8E58-72E28E3F24A0 wds:Q33889548-088910C3-1F08-4ED0-8F8C-3E61A152C4B6
wdt:P50
wd:Q56605609 wd:Q57033404 wd:Q54165911
p:P1476
wds:Q33889548-39D09D42-8C7C-4EFD-B6E6-942577A6CE82
wdt:P1476
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial
p:P304
wds:Q33889548-8D482189-2C49-473B-80E6-FE0342AFF4F9
wdt:P304
R24
p:P31
wds:Q33889548-6AE879B3-17B9-47F8-A9ED-C4D47BA5A197
wdt:P31
wd:Q13442814
p:P698
wds:Q33889548-260FC460-5F91-4A89-9B3B-37500F372D8B
wdtn:P698
n11:20398352
wdt:P698
20398352
p:P1433
wds:Q33889548-0F33B139-E7CA-4864-8C0C-6F860BDD274D
wdt:P1433
wd:Q2208481
p:P433
wds:Q33889548-19BF407B-2C9B-476E-88AB-7A8512D6DF23
p:P478
wds:Q33889548-425E92D1-B6C0-4C63-A584-69AB52A0D068
wdt:P433
2
wdt:P478
12
p:P356
wds:Q33889548-341FA87E-E477-42AD-892F-A81AA55D0DA8
wdtn:P356
n13:BCR2565
wdt:P356
10.1186/BCR2565
p:P5875
wds:Q33889548-E415ED95-D935-490B-8406-9C02E98B8E6F
wdt:P5875
43180985
p:P6179
wds:Q33889548-A8AA093C-DD36-4E4F-BBEC-2FAAAB80334A
wdt:P6179
1045867694
p:P932
wds:Q33889548-D29345AE-0BD0-46A6-A9FC-DF2244853D62
wdt:P932
2879572